Nephros Announces Preliminary Financial Results for Fiscal Year 2018
Nephros, Inc. (NEPH)
NASDAQ:AMEX Investor Relations:
nephros.com/investor-relations
Company Research
Source: GlobeNewswire
Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced preliminary financial results for fiscal year 2018. Total revenues for 2018 are expected to be between $5.6 and $5.7 million, an increase of 47-to-50% over 2017. Product revenues for 2018 are expected to be approximately $5.4 million, an increase of 53% over 2017. “We continue to achieve strong year-over-year sales growth as we build a firm business foundation and execute on our strategy,” said Daron Evans, President and Chief Executive Officer. “We expect to continue our current trajectory into 2019. The addition of Biocon into the Nephros family provides additional revenue potential in our core hospital market and exciting growth opportunities in new markets. We are bullish
Show less
Read more
Impact Snapshot
Event Time:
NEPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEPH alerts
High impacting Nephros, Inc. news events
Weekly update
A roundup of the hottest topics
NEPH
News
- Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewswire
- Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewswire
NEPH
Sec Filings
- 4/12/24 - Form ARS
- 4/12/24 - Form DEFA14A
- 4/12/24 - Form DEF
- NEPH's page on the SEC website